ArticleScientific reports2022
An innovative green synthesis approach of chitosan nanoparticles and their inhibitory activity against phytopathogenic Botrytis cinerea on strawberry leaves.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 109 citations in OpenAlex.
- Nanopolysaccharides in agriculture. Advances, applications, and future prospects: a review.Discover nano · 2026Review
- Review
- Sargassum tenerrimum Extract-Loaded Functional Nanochitosan with Enhanced Antimicrobial, Antioxidant and Cytotoxic Activity for Bioactive Textile Coatings.Cell biochemistry and biophysics · 2026Article
- Nano-enabled spray-induced RNA interference against fungal pathogens of oilseed crops: carrier performance, delivery evidence and field translation.World journal of microbiology & biotechnology · 2026Review
- Chitosan-Based Active Packaging for Shrimp Preservation: Development, Functionalization, and Industrial Prospects.Foods (Basel, Switzerland) · 2026Review
- Basic Substances and Nanotechnology: Bridging Sustainability and Innovation for Fungal Disease Management in Plants.Plants (Basel, Switzerland) · 2026Review
- Innovative mycosynthesis of chitosan nanoparticles via bionanofactory Penicillium crustosum: optimization, characterization, and application against building-deteriorating fungus, Trichosporon asahii.Biotechnology for biofuels and bioproducts · 2026Article
- Plant-derived chitosan nanoparticles: antibacterial and improved crop performance under drought stress.PeerJ · 2026Article
- Biofabrication, statistical optimization, and characterization of collagen nanoparticles synthesized via Streptomyces cell-free system for cancer therapy.Scientific reports · 2025Article
- Encapsulated citrus peel essential oil in pegylated mesoporous silica nanoparticles for postharvest control of Botrytis cinerea in strawberry.Scientific reports · 2025Article
- Proteomic Insights into the Interaction of Chitosan Nanoparticles with Canine MDCK Epithelial Cells.Molecules (Basel, Switzerland) · 2025Article
- New observations in the spores and hyphae of Colletotrichum siamense exposed to nanochitosan particles.Archives of microbiology · 2025Article
- Sustainable production of bacterial nanocellulose from date fruit waste using Bacillus haynesii for waste valorisation and crystal violet dye removal.Scientific reports · 2025Article
- Surface Treatment of Polyamide 6 through Enzymatic Hydrolysis and Covalent Incorporation of Chitosan Nanoparticles.Biomacromolecules · 2025Article
- Chitosan nanoparticles loaded withHeliyon · 2025Article
- Chitosan Nanoparticle-EncapsulatedInternational journal of molecular sciences · 2025Article
- Enhancing the Therapeutic Effect and Bioavailability of Irradiated Silver Nanoparticle-Capped Chitosan-Coated Rosuvastatin Calcium Nanovesicles for the Treatment of Liver Cancer.Pharmaceutics · 2025Article
- Artificial intelligence-based optimization for extracellular L-glutaminase free L-asparaginase production by Streptomyces violaceoruber under solid state fermentation conditions.Scientific reports · 2024Article
- Assessment of the Biocontrol Efficacy of Silver Nanoparticles Synthesized byLife (Basel, Switzerland) · 2024Article
- Green Fabrication of Silver Nanoparticles, Statistical Process Optimization, Characterization, and Molecular Docking Analysis of Their Antimicrobial Activities onto Cotton Fabrics.Journal of functional biomaterials · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green synthesis is a newly emerging field of nanobiotechnology that offers economic and environmental advantages over traditional chemical and physical protocols. Nontoxic, eco-friendly, and biosafe materials are used to implement sustainable processes. The current work proposes a new biological-based strategy for the biosynthesis of chitosan nanoparticles (CNPs) using Pelargonium graveolens leaves extract. The bioconversion process of CNPs was maximized using the response surface methodology. The best combination of the tested parameters that maximized the biosynthesis process was the incubation of plant extract with 1.08% chitosan at 50.38 °C for 57.53 min., yielding 9.82 ± 3 mg CNPs/mL. Investigation of CNPs by SEM, TEM, EDXS, zeta potential, FTIR, XRD, TGA, and DSC proved the bioconversion process's success. Furthermore, the antifungal activity of the biosynthesized CNPs was screened against a severe isolate of the phytopathogenic Botrytis cinerea. CNPs exerted efficient activity against the fungal growth. On strawberry leaves, 25 mg CNPs/mL reduced the symptoms of gray mold severity down to 3%. The higher concentration of CNPs (50 mg/mL) was found to have a reverse effect on the infected area compared with those of lower concentrations (12.5 and 25 mg CNPs/mL). Therefore, additional work is encouraged to reduce the harmful side effects of elevated CNPs concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.